Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 21, 2009
Mon, July 20, 2009
DDSS, UNH, HTGC, LL, SFD, CVH. Top Losing Stocks With Negative Price Friction In Morning Trade Today
July 20, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for July 20, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This afair market makinga requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the top companies with the largest losses this morning and negative price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Labopharm (NASDAQ: DDSS), Unitedhealth Group (NYSE: UNH), Hercules Technology Growth Capital (NASDAQ: HTGC), Lumber Liquidators (NYSE: LL), Smithfield Foods (NYSE: SFD) and Coventry Health Care (NYSE: CVH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction
DDSS -$0.68 -32.54% 170,574 35.53% 186,597 38.87% -16,023 -236
UNH -$0.62 -2.47% 415,697 36.78% 495,847 43.87% -80,150 -1,293
HTGC -$0.53 -5.55% 20,595 32.18% 41,777 65.27% -21,182 -400
LL -$0.46 -2.79% 9,250 24.44% 24,400 64.46% -15,150 -329
SFD -$0.43 -3.24% 127,394 41.46% 145,400 47.32% -18,006 -419
CVH -$0.40 -2.13% 40,279 31.22% 46,279 35.87% -6,000 -150
Click here to view chart: 
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows DDSS with a dollar loss this morning of -$0.68 and a Friction Factor of -236 shares. That means that it only takes 236 more shares of selling than buying to move DDSS lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.
Labopharm Inc. (NASDAQ: DDSS), a specialty pharmaceutical company, develops drugs by incorporating its proprietary controlled-release technologies. It offers once-daily formulation of the analgesic tramadol under the RYZOLT brand name for the treatment of severe chronic pain in adults. The company sells RYZOLT primarily in the United States, Europe, Canada, South Korea, and Australia. Labopharma�s products in pipeline include once-daily formulation of trazodone, a serotonin antagonist reuptake inhibitor for the treatment of depressive disorder. Its product candidates in clinical development based on Contramid platform comprise twice-daily formulation of tramadol plus acetaminophen to address acute pain; and Abuse Deterrent Platform to provide safer medications through resistance to the uncontrolled release of the active ingredient after actions, such as breaking, chewing, crushing and heating, or consumption with alcohol. Its product candidates in clinical development based on the Polymeric Nano-Delivery System platform comprise lipid-and preservative-free formulation of the intravenous anaesthetic agent propofol; and SN-38, which is the active metabolite in the prescribed intravenous colon cancer drug irinotecan. Labopharm was formerly known as Centre de recherche appliquee pharmaceutique CRAP inc. and changed its name to Labopharm Inc. in September 1994. The company was founded in 1990 and is headquartered in Laval, Canada.
UnitedHealth Group Incorporated (NYSE: UNH) provides healthcare services in the United States. The companya�s Health Care Services segment offers consumer-oriented health benefit plans and services; administrative and other management services to customers that self-insure the medical costs of their employees and their dependents; and non-employer based insurance options for purchase by individuals, which are designed to meet the health coverage needs of consumers. This segment also delivers health care and well-being services to large national employers, public sector employers, mid-sized employers, small businesses, and individuals. In addition, it provides health and well-being services for individuals aged 50 and older, addressing their needs for preventive and acute health care services, as well as for services dealing with chronic disease and other specialized issues for older individuals; health insurance products and services; and network-based health and well-being services to beneficiaries and other government-sponsored health care programs. Its OptumHealth segment provides health, financial, and ancillary services to people and organizations through personalized health advocacy and engagement; and specialized benefits, such as behavioral, dental and vision offerings, and health-based financial services. The companya�s Ingenix segment offers database and data management services, software products, publications, consulting services, outsourced services, and pharmaceutical data consulting and research services. Its Prescription Solutions segment provides a suite of integrated pharmacy benefit management and specialty pharmacy management services to employer groups, union trusts, and seniors through Medicare prescription drug plans and commercial health plans. As of December 31, 2008, it offered its services and resources through 580,000 physicians and other care providers, and 4,900 hospitals. The company was founded in 1974 and is based in Minnetonka, Minnesota.
Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC) is a private equity and venture capital firm specializing in growth, early, mid, and later stage investments. The firm also provides private equity for recapitalizations, leveraged buyouts, and spin-off transactions. It is a SBIC. The firm also provides public to private financings, including PIPEa�s. It invests in the form of equity, senior and subordinated working capital loan, senior revolving loan, bridge loan, and equipment loans. The firm prefers to invest in technology and life sciences related companies. In the technology sub-sectors, it seek companies characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure or services, Internet consumer and business services, telecommunications, telecommunications equipment, media, and life sciences. Within the life sciences sub-sector, the firm focuses on medical devices, bio-pharmaceutical, biotechnology, health care services, and information systems companies. It provides loans ranging from $1 million to $20 million and can underwrite transactions up to $30 million. The firm prefers to be the first debt provider but can also work with existing debt providers. Hercules Technology Growth Capital, Inc. was founded in 2003 and is headquartered in Palo Alto, California with additional offices across North America.
Lumber Liquidators, Inc. (NYSE: LL) operates as a specialty retailer of hardwood flooring in the United States. It offers an assortment of hardwood flooring that includes prefinished premium domestic and exotic hardwoods, engineered hardwoods, unfinished hardwoods, bamboo, cork, and laminates. The company also provides flooring enhancements and installation accessories, including moldings, noise-reducing underlay, and adhesives. It offers its products primarily under Lumber Liquidators and Bellawood brand names. The company markets its products through integrated sales channels comprising stores, a call center, lumberliquidators.com Web site, and a catalog. As of March 3, 2009, it operated 157 stores in 44 states. The company was founded in 1994 and is headquartered in Toano, Virginia.
Smithfield Foods, Inc. (NYSE: SFD), together with its subsidiaries, engages in the production and marketing of fresh meat and packaged meat products in the United States and internationally. It involves in the production of hog, processing of pork, production of turkey, and live cattle operations. The company offers fresh pork to retail customers as unprocessed, and trimmed cuts, such as butts, loins, picnics, and ribs; packaged meat products, including smoked and boiled hams, bacons, sausages, hot dogs, deli and luncheon meats, pepperoni, dry meat products, beef, and poultry, as well as ready-to-eat prepared foods, such as pre-cooked entrees, and pre-cooked bacons and sausages. It sells its products to supermarket chains; wholesale distributors; the foodservice industry, including fast food, restaurant and hotel chains, hospitals, and other institutional customers; export markets, and other further processors. The company sells its products through its salespersons and independent commission brokers. Smithfield Foods, Inc. was founded in 1961 and is headquartered in Smithfield, Virginia.
Coventry Health Care, Inc. (NYSE: CVH) operates as a managed healthcare company in the United States. The company operates health plans, insurance companies, and network rental and workersa� compensation services companies. Its Commercial Business division provides various products, including health maintenance organization (HMO), preferred provider organizations (PPO), and point of service products. This division also offers commercial management services products; and consumer-directed benefit options, including health reimbursement accounts and health savings accounts. The companya�s Individual Consumer and Government division offers health benefits to members participating in the Medicare Advantage HMO, Medicare Advantage PPO, Medicare Advantage Private-Fee-For-Service, Medicare Prescription Drug, and Medicaid programs. This division also provides fully-insured managed care services, as well as other products and services, such as pharmacy benefit management, clinical management, and fiscal intermediary services. Its Specialty Business division offers various products, including access to provider network, pharmacy benefits management, field case management, telephonic case management, independent medical exam, and bill review capabilities; and network rental services and other managed care products through a PPO network to national, regional, and local third party administrators and insurance carriers. This division also includes mental-behavioral health benefits business and dental benefits business. The company markets its products and services to individuals, employer and government-funded groups, government agencies, insurance carriers, and administrators through direct sales staff and a network of independent brokers. Coventry Health Care, Inc. was founded in 1986 and is based in Bethesda, Maryland.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,550,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net
- WOPRAI
- support@woprai.com
- www.woprai.com